Cystic Fibrosis 2018

Recently two new biological markers are identified for cystic fibrosis (CF), a inherited disease which affects children and young adults, leaving them with lifelong health complications including gastrointestinal problems and persistent lung infections.  The recent research shed new light on the underlying mechanisms of Cystic Fibrosis which could lead to improved prognosis and exceptional therapies for a disease which is quite variable, affecting different children in different ways. There are chemical signatures in sweat that tell us an infant has CF or not. The chemical indicators detected in sweat that could complement the gold standard for CF diagnosis is with the help of sweat chloride test. The test is commonly used in universal neonatal screening programs and measures the concentrations of salt. Increased sweat chloride confirms that an infant actually has CF. "Sweat contains lots of information related to human health and there are also some unexpected chemical

Cystic Fibrosis conference has created a platform for all the Pulmonologists and Researchers to share their innovative views about this multi system chronic disease. There are different techniques and methods involved which influenced human health with the help of safe medicines and techniques. Cystic fibrosis is the most typical, critical, recessively genetic disease of Caucasian populations. Genotyping technology has some limitations which includes the choice of mutations to be tested, and also the clinical context in which the test is administered. It affects approximately over 70,000 people worldwide. This happens because of the mutations in the CFTR gene sequence. These all manifestations can influence the genetic information. It is often challenging in clinical Cystic fibrosis to interpret molecular genetic results, and to integrate them. To know more about this evolving topic let us join the upcoming huge conference i.e. International conference on Cystic Fibrosis w